Xylem Reports Third Quarter 2022 Results

Lifting full-year organic revenue growth guidance to 9% to 10%, from 8% to 10% Raising full-year adjusted EPS guidance to $2.65 to $2.75, from $2.50 to $2.70 Third quarter revenue growth of 9% on a reported basis, 16% organically Reported earnings per share of $0.07, adjusted earnings per share of $0.79

Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today reported third quarter revenue of $1.4 billion, surpassing previous guidance, with strong commercial and operational execution. While orders were down 7 percent on a reported basis, they were down 1 percent organically, with the difference due to currency. The Company reported resilient underlying global demand with strong backlog growth.

Earnings also exceeded Xylem’s previous guidance, with strong margin performance. Net income was $12 million, or $0.07 per share. Net income margin decreased 810 basis points to 0.9 percent. These results were mainly driven by a previously announced, one-time non-cash pension plan settlement. Adjusted net income was $144 million, or $0.79 per share, which excludes the impacts of restructuring, realignment and special charges. Third quarter adjusted earnings before interest, tax, depreciation and amortization (EBITDA) margin was 18.3 percent, reflecting a year-over-year increase of 40 basis points. Strong price realization offset inflation and, coupled with productivity savings, drove the margin expansion, exceeding the impact of strategic investments.

“The team delivered very strong performance across all our regions, driving third quarter results well above expectations on all key metrics,” said Patrick Decker, Xylem president and CEO. “Demand remains resilient across our largest end-markets, and disciplined operational execution delivered double-digit revenue growth with strong margin expansion.”

“We anticipate our momentum will continue driven by the essential nature of the services we provide. Our strong backlog and bidding pipelines support that outlook. The team, from our factories to our channel partners, continues to demonstrate resilience in managing through a dynamic environment, as our customers and communities invest in essential water infrastructure. Based on this strength, we are further raising our full-year guidance for both revenue and earnings per share, with continued confidence in Xylem’s longer-term growth outlook.”

Outlook

Xylem now expects full-year 2022 organic revenue growth to be in the range of 9 to 10 percent, and approximately 4 percent on a reported basis. This represents a raise of the low end of the Company’s previous full-year organic revenue guidance of 8 to 10 percent, and 3 to 5 percent on a reported basis. Full-year 2022 adjusted EBITDA margin is now expected to be approximately 17.0 percent, raising the low end of the previous range of 16.5 to 17.0 percent. This results in adjusted earnings per share of $2.65 to $2.75, an increase from the previous range of $2.50 to $2.70. The increased guidance reflects strong demand, gradual easing of supply chain constraints, and price realization, partially offset by inflation and foreign exchange headwinds.

Further 2022 planning assumptions are included in Xylem’s third quarter 2022 earnings materials posted at www.xylem.com/investors. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.

Third Quarter Segment Results

Water Infrastructure

Xylem’s Water Infrastructure segment consists of its portfolio of businesses serving clean water delivery, wastewater transport and treatment, and dewatering.

• Third quarter 2022 revenue was $574 million, a 5 percent increase, 13 percent organically, compared with third quarter 2021. This strong growth was driven by price realization, robust utilities demand in the US and Western Europe, and dewatering demand in the US and Emerging Markets.

• Third quarter reported operating income for the segment was $104 million, a 3.0 percent increase versus the comparable period last year. Adjusted operating income for the segment, which excludes $3 million of restructuring and realignment costs, was $107 million, a 4.9 percent increase versus the comparable period last year. Reported operating margin for the segment was 18.1 percent, down 40 basis points versus the prior year, and adjusted operating margin was 18.6 percent, flat versus the prior year. Adjusted EBITDA margin was 20.7 percent, down 50 basis points from the prior year. Favorable price realization net of inflation was offset by strategic investments and unfavorable mix.

Applied Water

Xylem’s Applied Water segment consists of its portfolio of businesses in industrial, commercial building, and residential applications.

• Third quarter 2022 Applied Water revenue was $458 million, a 15 percent increase, 20 percent organically, year-over-year. The robust growth was driven by strong price realization and backlog execution across all end markets.

• Third quarter reported operating income for the segment was $77 million, a 28.3 percent increase versus comparable period last year, and adjusted operating income, which excludes $1 million of restructuring and realignment costs, was $78 million, a 25.8 percent increase versus the comparable period last year. The segment reported operating margin was 16.8 percent, up 180 basis points versus the prior year period. Adjusted operating margin increased 150 basis points over the prior year period to 17.0 percent. Adjusted EBITDA margin was 18.1 percent, up 110 basis points from the prior year. Margin expansion was driven by strong price realization more than offsetting inflation coupled with productivity savings.

Measurement & Control Solutions

Xylem’s Measurement & Control Solutions segment consists of its portfolio of businesses in smart metering, network technologies, advanced infrastructure analytics, and analytic instrumentation.

• Third quarter 2022 Measurement & Control Solutions revenue was $348 million, up 9 percent, 15 percent organically, versus the prior year. While chip supply remains constrained, we continue to see modest sequential improvement, and strength in our water quality test applications.

• Third quarter reported operating income for the segment was $(2) million, a 128.6 percent decrease versus the comparable period last year, and adjusted operating income, which excludes $2 million of restructuring and realignment costs and $12 million of special charges, was $12 million, a 100 percent increase versus the comparable period last year. The segment reported operating margin was (0.6) percent, down 280 basis points versus the prior year period. Adjusted operating margin of 3.4 percent increased 150 basis points over the prior year period. Adjusted EBITDA margin was 13.8 percent, down 40 basis points from the prior year. Strong price realization, volume growth and productivity savings were more than offset by higher inflation.

Supplemental information on Xylem’s third quarter 2022 earnings and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.

About Xylem

Xylem (XYL) is a leading global water technology company committed to solving critical water and infrastructure challenges with innovation. Our 17,000 diverse employees delivered revenue of $5.2 billion in 2021. We are creating a more sustainable world by enabling our customers to optimize water and resource management, and helping communities in more than 150 countries become water-secure. Join us at www.xylem.com.

Forward-Looking Statements

This press release contains “forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” "contemplate," "predict," “forecast,” “likely,” “believe,” “target,” “will,” “could,” “would,” “should,” "potential," "may" and similar expressions or their negative, may, but are not necessary to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that are not historical, such as statements about our strategy, financial plans, outlook, objectives, plans, intentions or goals (including those related to our social, environmental and other sustainability goals); or address possible or future results of operations or financial performance, including statements relating to orders, revenues, operating margins and earnings per share growth.

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Additionally, many of these risks and uncertainties are, and may continue to be, amplified by impacts from changes in international conditions, including as a result of the war between Russia and Ukraine, the coronavirus (“COVID-19”) pandemic and macroeconomic conditions, including inflation. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include, among others, the following: the impact of overall industry and general economic conditions, including industrial, governmental, and public and private sector spending, inflation, interest rates and related monetary policy by governments in response to inflation, and the strength of the residential and commercial real estate markets, on economic activity and our operations; geopolitical events, including the war between Russia and Ukraine, and regulatory, economic and other risks associated with our global sales and operations, including with respect to domestic content requirements applicable to projects with governmental funding; continued uncertainty around the ongoing impacts of the COVID-19 pandemic on the macroeconomy and our business, operations, growth, and financial condition; actual or potential other epidemics, pandemics or global health crises; availability, shortage or delays in receiving electronic components (in particular, semiconductors), parts, and raw materials from our supply chain; manufacturing and operating cost increases due to macroeconomic conditions, including inflation, energy supply, supply chain shortages, logistics challenges, tight labor markets, prevailing price changes, tariffs and other factors; demand for our products; disruption, competition or pricing pressures in the markets we serve; cybersecurity incidents or other disruptions of information technology systems on which we rely, or involving our products; disruptions in operations at our facilities or that of third parties upon which we rely; ability to retain and attract senior management and other diverse and key talent, as well as competition for overall talent and labor; difficulty predicting our financial results; defects, security, warranty and liability claims, and recalls with respect to products; availability, regulation or interference with radio spectrum used by certain of our products; uncertainty related to restructuring and realignment actions and related costs and savings; our ability to continue strategic investments for growth; our ability to successfully identify, execute and integrate acquisitions; volatility in served markets or impacts on business and operations due to weather conditions, including the effects of climate change; fluctuations in foreign currency exchange rates; our ability to borrow or refinance our existing indebtedness and uncertainty around the availability of liquidity sufficient to meet our needs; risk of future impairments to goodwill and other intangible assets; failure to comply with, or changes in, laws or regulations, including those pertaining to anti-corruption, data privacy and security, export and import, our products, competition, and the environment and climate change; changes in our effective tax rates or tax expenses; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2021 ("2021 Annual Report") and in subsequent filings we make with the Securities and Exchange Commission (“SEC”).

Forward-looking and other statements in this press release regarding our environmental and other sustainability plans and goals are not an indication that these statements are necessarily material to investors or are required to be disclosed in our filings with the SEC. In addition, historical, current, and forward-looking social, environmental and sustainability related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future. All forward-looking statements made herein are based on information currently available to us as of the date of this Report. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)
(in millions, except per share data)
	Three Months							Nine Months
For the periods ended September 30,	2022			2021				2022			2021
Revenue	$	1,380		$	1,265			$	4,016		$	3,872
Cost of revenue		856			793				2,505			2,390
Gross profit		524			472				1,511			1,482
Selling, general and administrative expenses		294			273				912			878
Research and development expenses		47			49				152			152
Restructuring and asset impairment charges (recoveries)		15			(2	)			22			7
Operating income		168			152				425			445
Interest expense		12			21				37			63
U.K. pension settlement expense		140			—				140			—
Other non-operating income, net		1			2				2			1
Gain from sale of business		—			—				1			2
Income before taxes		17			133				251			385
Income tax expense		5			19				45			71
Net income	$	12		$	114			$	206		$	314
Earnings per share:
Basic	$	0.07		$	0.63			$	1.14		$	1.74
Diluted	$	0.07		$	0.63			$	1.14		$	1.73
Weighted average number of shares:
Basic		180.2			180.2				180.2			180.2
Diluted		180.9			181.6				180.9			181.5

XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(in millions, except per share amounts)
	September 30, 2022				December 31, 2021
ASSETS
Current assets:
Cash and cash equivalents	$	1,186			$	1,349
Receivables, less allowances for discounts, returns and credit losses of $46 and $44 in 2022 and 2021, respectively		1,018				953
Inventories		837				700
Prepaid and other current assets		150				158
Total current assets		3,191				3,160
Property, plant and equipment, net		585				644
Goodwill		2,637				2,792
Other intangible assets, net		933				1,016
Other non-current assets		760				664
Total assets	$	8,106			$	8,276
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	618			$	639
Accrued and other current liabilities		828				752
Short-term borrowings and current maturities of long-term debt		483				—
Total current liabilities		1,929				1,391
Long-term debt		1,880				2,440
Accrued post-retirement benefits		361				438
Deferred income tax liabilities		260				287
Other non-current accrued liabilities		454				494
Total liabilities		4,884				5,050
Stockholders’ equity:
Common Stock – par value $0.01 per share:
Authorized 750.0 shares, issued 196.0 shares and 195.6 shares in 2022 and 2021, respectively		2				2
Capital in excess of par value		2,123				2,089
Retained earnings		2,197				2,154
Treasury stock – at cost 15.8 shares and 15.2 shares in 2022 and 2021, respectively		(708	)			(656	)
Accumulated other comprehensive loss		(399	)			(371	)
Total stockholders’ equity		3,215				3,218
Non-controlling interests		7				8
Total equity		3,222				3,226
Total liabilities and stockholders’ equity	$	8,106			$	8,276

XYLEM INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (in millions)
For the nine months ended September 30,	2022				2021
Operating Activities
Net income	$	206			$	314
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation		83				90
Amortization		93				96
Share-based compensation		28				25
Restructuring and asset impairment charges		22				7
U.K. pension settlement		140				—
Gain from sale of business		(1	)			(2	)
Other, net		(9	)			3
Payments for restructuring		(7	)			(21	)
Changes in assets and liabilities (net of acquisitions):
Changes in receivables		(145	)			(78	)
Changes in inventories		(214	)			(135	)
Changes in accounts payable		47				19
Changes in accrued taxes		(12	)			—
Other, net		3				—
Net Cash – Operating activities		234				318
Investing Activities
Capital expenditures		(148	)			(127	)
Proceeds from sale of business		1				2
Proceeds from the sale of property, plant and equipment		3				1
Cash received from investments		5				—
Cash paid for investments		(9	)			—
Cash received from cross currency swaps		24				11
Other, net		1				—
Net Cash – Investing activities		(123	)			(113	)
Financing Activities
Long-term debt repaid		—				(600	)
Repurchase of common stock		(52	)			(68	)
Proceeds from exercise of employee stock options		6				15
Dividends paid		(163	)			(152	)
Other, net		(1	)			(1	)
Net Cash – Financing activities		(210	)			(806	)
Effect of exchange rate changes on cash		(64	)			(19	)
Net change in cash and cash equivalents		(163	)			(620	)
Cash and cash equivalents at beginning of year		1,349				1,875
Cash and cash equivalents at end of period	$	1,186			$	1,255
Supplemental disclosure of cash flow information:
Cash paid during the period for:
Interest	$	67			$	83
Income taxes (net of refunds received)	$	57			$	71

Xylem Inc. Non-GAAP Measures

Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following items to represent the non-GAAP measures we consider to be key performance indicators, as well as the related reconciling items to the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures may not be comparable to similarly titled measures reported by other companies.

“Organic revenue" and "Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales or discontinuance of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.

“Constant currency” defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the US dollar.

“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” and "Adjusted Segment EBITDA" reflect the adjustments to EBITDA and segment EBITDA, respectively, to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.

"Adjusted EBITDA Margin" and "Adjusted Segment EBITDA Margin" defined as adjusted EBITDA and adjusted segment EBITDA divided by total revenue and segment revenue, respectively.

"Adjusted Operating Income", "Adjusted Segment Operating Income", "Adjusted Net Income" and “Adjusted EPS” defined as operating income, segment operating income, net income and earnings per share, adjusted to exclude restructuring and realignment costs, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.

"Adjusted Operating Margin" and "Adjusted Segment Operating Margin" defined as adjusted operating income and adjusted segment operating income divided by total revenue and segment revenue, respectively.

“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flows, less capital expenditures, and "Free Cash Flow Conversion" defined as Free Cash Flows divided by net income, excluding the gain on sale of businesses, non-cash impairment charges and significant deferred tax items. Our definitions of "free cash flow" and "free cash flow conversion" do not consider certain non-discretionary cash payments, such as debt.

“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.

“Special charges" defined as costs incurred by the Company, such as acquisition and integration related costs, non-cash impairment charges and both operating and non-operating adjustments for costs related to the UK pension plan buyout.

“Tax-related special items" defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, excess tax benefits/losses and other discrete tax adjustments.

Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Orders ($ Millions)
		(As Reported - GAAP)										(As Adjusted - Organic)										Constant Currency
				(A)		(B)						(C)		(D)		(E) = B+C+D			(F) = E/A			(G) = (E - C) / A
						Change			% Change			Acquisitions / Divestitures				Change			% Change
		Orders		Orders		2022 v. 2021			2022 v. 2021					FX Impact		Adj. 2022 v. 2021			Adj. 2022 v. 2021
		2022		2021
Nine Months Ended September 30
Xylem Inc.		4,818		4,716		102			2	%		18		189		309			7	%		6	%
Water Infrastructure		1,985		1,873		112			6	%		0		113		225			12	%		12	%
Applied Water		1,394		1,409		(15	)		-1	%		0		45		30			2	%		2	%
Measurement & Control Solutions		1,439		1,434		5			0	%		18		31		54			4	%		3	%
Quarter Ended September 30
Xylem Inc.		1,419		1,518		(99	)		-7	%		7		82		(10	)		-1	%		-1	%
Water Infrastructure		594		623		(29	)		-5	%		0		47		18			3	%		3	%
Applied Water		409		446		(37	)		-8	%		0		20		(17	)		-4	%		-4	%
Measurement & Control Solutions		416		449		(33	)		-7	%		7		15		(11	)		-2	%		-4	%
Quarter Ended June 30
Xylem Inc.		1,684		1,660		24			1	%		5		67		96			6	%		5	%
Water Infrastructure		731		639		92			14	%		0		42		134			21	%		21	%
Applied Water		480		486		(6	)		-1	%		0		15		9			2	%		2	%
Measurement & Control Solutions		473		535		(62	)		-12	%		5		10		(47	)		-9	%		-10	%
Quarter Ended March 31
Xylem Inc.		1,715		1,538		177			12	%		6		40		223			14	%		14	%
Water Infrastructure		660		611		49			8	%		0		24		73			12	%		12	%
Applied Water		505		477		28			6	%		0		10		38			8	%		8	%
Measurement & Control Solutions		550		450		100			22	%		6		6		112			25	%		24	%

Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Revenue ($ Millions)
		(As Reported - GAAP)										(As Adjusted - Organic)										Constant Currency
				(A)		(B)						(C)		(D)		(E) = B+C+D			(F) = E/A			(G) = (E - C) / A
						Change			% Change			Acquisitions / Divestitures				Change			% Change
		Revenue		Revenue		2022 v. 2021			2022 v. 2021					FX Impact		Adj. 2022 v. 2021			Adj. 2022 v. 2021
		2022		2021
Nine Months Ended September 30
Xylem Inc.		4,016		3,872		144			4	%		9		173		326			8	%		8	%
Water Infrastructure		1,696		1,625		71			4	%		0		99		170			10	%		10	%
Applied Water		1,312		1,207		105			9	%		0		44		149			12	%		12	%
Measurement & Control Solutions		1,008		1,040		(32	)		-3	%		9		30		7			1	%		0	%
Quarter Ended September 30
Xylem Inc.		1,380		1,265		115			9	%		4		80		199			16	%		15	%
Water Infrastructure		574		547		27			5	%		0		46		73			13	%		13	%
Applied Water		458		400		58			15	%		0		21		79			20	%		20	%
Measurement & Control Solutions		348		318		30			9	%		4		13		47			15	%		14	%
Quarter Ended June 30
Xylem Inc.		1,364		1,351		13			1	%		3		60		76			6	%		5	%
Water Infrastructure		589		569		20			4	%		0		34		54			9	%		9	%
Applied Water		429		414		15			4	%		0		15		30			7	%		7	%
Measurement & Control Solutions		346		368		(22	)		-6	%		3		11		(8	)		-2	%		-3	%
Quarter Ended March 31
Xylem Inc.		1,272		1,256		16			1	%		2		33		51			4	%		4	%
Water Infrastructure		533		509		24			5	%		0		19		43			8	%		8	%
Applied Water		425		393		32			8	%		0		8		40			10	%		10	%
Measurement & Control Solutions		314		354		(40	)		-11	%		2		6		(32	)		-9	%		-10	%

Xylem Inc. Non-GAAP Reconciliation
Adjusted Operating Income ($ Millions)
		Q1					Q2					Q3					YTD
		2022		2021			2022		2021			2022		2021			2022		2021
Total Revenue
• Total Xylem		1,272		1,256			1,364		1,351			1,380		1,265			4,016		3,872
• Water Infrastructure		533		509			589		569			574		547			1,696		1,625
• Applied Water		425		393			429		414			458		400			1,312		1,207
• Measurement & Control Solutions		314		354			346		368			348		318			1,008		1,040
Operating Income (Loss)
• Total Xylem		111		133			146		160			168		152			425		445
• Water Infrastructure		74		71			108		93			104		101			286		265
• Applied Water		59		66			61		64			77		60			197		190
• Measurement & Control Solutions		(10	)	9			(5	)	13			(2	)	7			(17	)	29
• Total Segments		123		146			164		170			179		168			466		484
Operating Margin
• Total Xylem		8.7	%	10.6	%		10.7	%	11.8	%		12.2	%	12.0	%		10.6	%	11.5	%
• Water Infrastructure		13.9	%	13.9	%		18.3	%	16.3	%		18.1	%	18.5	%		16.9	%	16.3	%
• Applied Water		13.9	%	16.8	%		14.2	%	15.5	%		16.8	%	15.0	%		15.0	%	15.7	%
• Measurement & Control Solutions		-3.2	%	2.5	%		-1.4	%	3.5	%		-0.6	%	2.2	%		-1.7	%	2.8	%
• Total Segments		9.7	%	11.6	%		12.0	%	12.6	%		13.0	%	13.3	%		11.6	%	12.5	%
Special Charges
• Total Xylem		1		2			1		0			13		1			15		3
• Water Infrastructure		0		0			0		0			0		0			0		0
• Applied Water		0		1			0		0			0							1
• Measurement & Control Solutions		0		0			1		0			12		0			13		0
• Total Segments		0		1			1		0			12		0			13		1
Restructuring & Realignment Costs
• Total Xylem		4		8			8		6			6		2			18		16
• Water Infrastructure		1		5			3		4			3		1			7		10
• Applied Water		1		1			2		2			1		2			4		5
• Measurement & Control Solutions		2		2			3		0			2		(1	)		7		1
• Total Segments		4		8			8		6			6		2			18		16
Adjusted Operating Income (Loss)
• Total Xylem		116		143			155		166			187		155			458		464
• Water Infrastructure		75		76			111		97			107		102			293		275
• Applied Water		60		68			63		66			78		62			201		196
• Measurement & Control Solutions		(8	)	11			(1	)	13			12		6			3		30
• Total Segments		127		155			173		176			197		170			497		501
Adjusted Operating Margin
• Total Xylem		9.1	%	11.4	%		11.4	%	12.3	%		13.6	%	12.3	%		11.4	%	12.0	%
• Water Infrastructure		14.1	%	14.9	%		18.8	%	17.0	%		18.6	%	18.6	%		17.3	%	16.9	%
• Applied Water		14.1	%	17.3	%		14.7	%	15.9	%		17.0	%	15.5	%		15.3	%	16.2	%
• Measurement & Control Solutions		-2.5	%	3.1	%		-0.3	%	3.5	%		3.4	%	1.9	%		0.3	%	2.9	%
• Total Segments		10.0	%	12.3	%		12.7	%	13.0	%		14.3	%	13.4	%		12.4	%	12.9	%

Xylem Inc. Non-GAAP Reconciliation
Adjusted Diluted EPS
($ Millions, except per share amounts)
			Q3 2022												Q3 2021
			As Reported				Adjustments				Adjusted				As Reported				Adjustments				Adjusted
	Total Revenue			1,380								1,380				1,265								1,265
	Operating Income			168				19		a		187				152				3		a		155
	Operating Margin			12.2	%							13.6	%			12.0	%							12.3	%
	Interest Expense			(12	)			0				(12	)			(21	)			0				(21	)
	Other Non-Operating Income (Expense)			1				1		b		2				2				1		b		3
	UK Pension Buyout Settlement			(140	)			140		b		0												0
	Gain/(Loss) From Sale of Business											0												0
	Income before Taxes			17				160				177				133				4				137
	Provision for Income Taxes			(5	)			(28	)	c		(33	)			(19	)			(2	)	c		(21	)
	Net Income Attributable to Xylem			12				132				144				114				2				116
	Diluted Shares			181								181				182								182
	Diluted EPS		$	0.07			$	0.72			$	0.79			$	0.63			$	0.00			$	0.63
	Year-over-year currency translation impact on current year diluted EPS		$	0.03			($	0.17	)		($	0.14	)
	Diluted EPS at Constant Currency		$	0.04			$	0.89			$	0.93
a	Quarter-to-date: Restructuring & realignment costs of $6 million in 2022 and $2 million in 2021, as well as special charges of $13 million in 2022 ($1 million UK pension plan charges and $12 million asset impairment charges) and $1 million in 2021 for UK pension plan charges.
b	Quarter-to-date: Special non-operating charges consist of $141 million in 2022 related to UK pension plan charges and buyout settlement and $1 million in 2021 for costs related to the UK pension plan.
c	Quarter-to-date: Net tax impact on restructuring & realignment costs of $1 million in 2022 and $1 million in 2021; net tax impact on special charges of $25 million in 2022; and $2 million in 2022 and $1 million in 2021 of negative impact from tax related special benefits to GAAP tax, respectively.

Xylem Inc. Non-GAAP Reconciliation
Net Cash - Operating Activities vs. Free Cash Flow ($ Millions)
		Q1						Q2						Q3						Year-to-Date
		2022			2021			2022			2021			2022			2021			2022			2021
Net Cash - Operating Activities		($81	)		($26	)		$113			$232			$202			$112			$234			$318
Capital Expenditures - PP&E		(31	)		(22	)		(30	)		(25	)		(37	)		(33	)		(98	)		(80	)
Capital Expenditures - Software		(18	)		(17	)		(16	)		(16	)		(16	)		(14	)		(50	)		(47	)
Capital Expenditures		(49	)		(39	)		(46	)		(41	)		(53	)		(47	)		(148	)		(127	)
Free Cash Flow		($130	)		($65	)		$67			$191			$149			$65			$86			$191
Net Income		82			87			112			113			12			114			206			314
Gain/(Loss) from sale of business		1			0			0			2			0			0			1			2
Restructuring & Realignment Charges - non-cash impairment		0			(1	)		0			0			0			0			0			(1	)
UK pension buyout settlement - non-cash release from AOCI		0			0			0			0			(140	)		0			(140	)		0
UK pension buyout settlement - non-cash tax release from AOCI		0			0			0			0			23			0			23			0
Special Charges - non-cash impairment		0			(1	)		(1	)		0			(12	)		0			(13	)		(1	)
Net Income, excluding gain on sale of businesses, non-cash impairment charges and non-cash pension buyout settlement		$81			$89			$113			$111			$141			$114			$335			$314
Operating Cash Flow Conversion		-99	%		-30	%		101	%		205	%		1683	%		98	%		114	%		101	%
Free Cash Flow Conversion		-160	%		-73	%		59	%		172	%		106	%		57	%		26	%		61	%

Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
2022
		Q1			Q2			Q3			Q4			Total
Net Income		82			112			12						206
Net Income margin		6.4	%		8.2	%		0.9	%					5.1	%
Depreciation		28			28			27						83
Amortization		30			32			31						93
Interest Expense (Income), net		11			10			7						28
Income Tax Expense		16			24			5						45
EBITDA		167			206			82						455
Share-based Compensation		9			9			10						28
Restructuring & Realignment		4			8			6						18
UK Pension Settlement		-			-			140						140
Special Charges		2			3			14						19
Loss/(Gain) from sale of business		(1	)		-			-						(1	)
Adjusted EBITDA		181			226			252						659
Adjusted EBITDA Margin		14.2	%		16.6	%		18.3	%					16.4	%
2021
		Q1			Q2			Q3			Q4			Total
Net Income		87			113			114			113			427
Net Income margin		6.9	%		8.4	%		9.0	%		8.5	%		8.2	%
Depreciation		30			29			31			28			118
Amortization		32			33			31			31			127
Interest Expense (Income), net		19			19			20			11			69
Income Tax Expense		27			25			19			13			84
EBITDA		195			219			215			196			825
Share-based Compensation		9			8			8			8			33
Restructuring & Realignment		8			6			2			6			22
Special Charges		3			3			2			4			12
Loss/(Gain) from sale of business		-			(2	)		-			-			(2	)
Adjusted EBITDA		215			234			227			214			890
Adjusted EBITDA Margin		17.1	%		17.3	%		17.9	%		16.2	%		17.1	%

Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
Water Infrastructure
2022
		Q1			Q2			Q3			Q4			Total
Operating Income		74			108			104						286
Depreciation		11			11			11						33
Amortization		2			3			1						6
Other non-operating expense, excluding interest income		(4	)		1			-						(3	)
EBITDA		83			123			116						322
Share-based Compensation		1			-			-						1
Restructuring & Realignment		1			3			3						7
Adjusted EBITDA		85			126			119						330
Adjusted EBITDA Margin		15.9	%		21.4	%		20.7	%					19.5	%
2021
		Q1			Q2			Q3			Q4			Total
Operating Income		71			93			101			122			387
Depreciation		11			11			11			10			43
Amortization		2			2			1			3			8
Other non-operating expense, excluding interest income		(2	)		(2	)		1			(2	)		(5	)
EBITDA		82			104			114			133			433
Share-based Compensation		1			-			1			-			2
Restructuring & Realignment		5			4			1			2			12
Adjusted EBITDA		88			108			116			135			447
Adjusted EBITDA Margin		17.3	%		19.0	%		21.2	%		21.7	%		19.9	%

Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
Applied Water
2022
		Q1			Q2			Q3			Q4			Total
Operating Income		59			61			77						197
Depreciation		5			4			4						13
Amortization		-			1			-						1
Other non-operating expense, excluding interest income		(1	)		-			(1	)					(2	)
EBITDA		63			66			80						209
Share-based Compensation		1			1			2						4
Restructuring & Realignment		1			2			1						4
Special Charges		-			-			-						-
Loss/(Gain) from sale of business		-			-			-						-
Adjusted EBITDA		65			69			83						217
Adjusted EBITDA Margin		15.3	%		16.1	%		18.1	%					16.5	%
2021
		Q1			Q2			Q3			Q4			Total
Operating Income		66			64			60			50			240
Depreciation		5			5			5			5			20
Amortization		1			1			-			-			2
Other non-operating expense, excluding interest income		-			(1	)		-			(2	)		(3	)
EBITDA		72			71			65			53			261
Share-based Compensation		1			1			1			1			4
Restructuring & Realignment		1			2			2			2			7
Special Charges		1			-			-			-			1
Loss/(Gain) from sale of business		-			(2	)		-			-			(2	)
Adjusted EBITDA		75			72			68			56			271
Adjusted EBITDA Margin		19.1	%		17.4	%		17.0	%		13.8	%		16.8	%

Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter ($ Millions)
Measurement & Control Solutions
2022
		Q1			Q2			Q3			Q4			Total
Operating Income		(10	)		(5	)		(2	)					(17	)
Depreciation		9			8			8						25
Amortization		25			26			27						78
Other non-operating expense, excluding interest income		-			(1	)		(1	)					(2	)
EBITDA		25			28			32						85
Share-based Compensation		1			2			2						5
Restructuring & Realignment		2			3			2						7
Adjusted EBITDA		27			34			48						109
Adjusted EBITDA Margin		8.6	%		9.8	%		13.8	%					10.8	%
2021
		Q1			Q2			Q3			Q4			Total
Operating Income		9			13			7			(17	)		12
Depreciation		9			10			11			8			38
Amortization		27			27			27			26			107
Other non-operating expense, excluding interest income		(1	)		(1	)		-			-			(2	)
EBITDA		44			49			45			17			155
Share-based Compensation		1			2			1			2			6
Restructuring & Realignment		2			-			(1	)		2			3
Adjusted EBITDA		47			51			45			21			164
Adjusted EBITDA Margin		13.3	%		13.9	%		14.2	%		7.1	%		12.3	%

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20221031005753/en/